描述

Arthritis refers to biomechanical changes within a joint. Osteoarthritis (OA) is the most common form of arthritis. It occurs most frequently in the hands, hips, and knees. A study by StrategyHelix indicates that the global osteoarthritis therapeutics market is expected to increase by US$ 3.36 十亿来自 2021 到 2027, 复合年增长率为 6.7% 在预测期内.

该报告提供了该时期的最新市场规模数据 2017-2020 并预测到 2027 covering key market aspects like sales value for osteoarthritis therapeutics. The global osteoarthritis therapeutics market is segmented on the basis of anatomy, 药品, drug classification, 和地区. Based on anatomy, the global osteoarthritis therapeutics market is categorized into knee osteoarthritis, hip osteoarthritis, 和别的. 全球范围, the knee osteoarthritis segment made up the largest share of the osteoarthritis therapeutics market. On the basis of drug, the global osteoarthritis therapeutics market has been segmented into viscosupplementation agents, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids. By drug classification, the global osteoarthritis therapeutics market has been segmented into prescription drugs, and OTC. 从地理上来说, the global osteoarthritis therapeutics market has been segmented into Asia Pacific, 欧洲, 北美, 和世界其他地区 (排).

The global osteoarthritis therapeutics market is highly competitive. 雅培实验室 (Abbott Laboratories) 是市场上的一些领先公司, Anika Therapeutics Inc., 拜耳公司, Bioventus Inc., 礼来公司, Ferring B.V., Fidia Farmaceutici S.p.A., Flexion Therapeutics Inc., 葛兰素史克公司, Horizon Therapeutics plc, 约翰逊 & 约翰逊, 诺华国际公司, 辉瑞公司, 赛诺菲公司, Seikagaku Corporation.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the osteoarthritis therapeutics market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

Anatomy: knee osteoarthritis, hip osteoarthritis, 和别的
Drug: viscosupplementation agents, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids
Drug classification: prescription drugs, and OTC
地区: 亚太地区, 欧洲, 北美, 和世界其他地区 (排)
考虑的年数: 本报告涵盖期间 2017 到 2027

利益相关者的主要好处

– Get a comprehensive picture of the global osteoarthritis therapeutics market
– 精准定位增长领域和投资趋势

目录

1. 市场定义
2. 研究方法论
3. 市场数据与展望
3.1 市场规模估计
3.2 预报
4. Osteoarthritis therapeutics market by anatomy
4.1 Knee osteoarthritis
4.2 Hip osteoarthritis
4.3 其他的
5. Osteoarthritis therapeutics market by drug
5.1 Viscosupplementation agents
5.2 Non-steroidal anti-inflammatory drugs (NSAIDs)
5.3 Analgesics
5.4 Corticosteroids
6. Osteoarthritis therapeutics market by drug classification
6.1 Prescription drugs
6.2 OTC
7. Osteoarthritis therapeutics market by region
7.1 亚太地区
7.2 欧洲
7.3 北美
7.4 世界其他地区 (排)
8. 公司简介
8.1 雅培实验室
8.2 Anika Therapeutics Inc.
8.3 拜耳公司
8.4 Bioventus Inc.
8.5 礼来公司
8.6 Ferring B.V.
8.7 Fidia Farmaceutici S.p.A.
8.8 Flexion Therapeutics, 公司.
8.9 葛兰素史克公司
8.10 Horizon Therapeutics plc
8.11 约翰逊 & 约翰逊
8.12 诺华国际公司
8.13 Pfizer Inc.
8.14 赛诺菲公司.
8.15 Seikagaku Corporation
9. 附录
9.1 关于StrategyHelix
9.2 免责声明